⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14190836 | 1.00 | — | — | |
| SCHEMBL3702162 | 1.00 | — | — | |
| SCHEMBL31650803 | 0.80 | — | — | |
| SCHEMBL20672987 | 0.79 | — | — | |
| SCHEMBL29596626 | 0.78 | KDM4E (0.58) | — | |
| SCHEMBL17826675 | 0.77 | — | — | |
| SCHEMBL19152276 | 0.77 | — | — | |
| SCHEMBL22028100 | 0.77 | — | — | |
| SCHEMBL3456469 | 0.76 | — | — | |
| SCHEMBL3456466 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250152647-A1 | FORMULATIONS AND METHODS FOR SKIN CARE | AMILYFE LLC (US) | 2025-05-15 | — | — | US | disclosed |
| US-12274729-B2 | Formulations and methods for skin care or hyaluronic acid synthesis | AMILYFE, LLC (US) | 2025-04-15 | — | — | US | disclosed |
| US-12239681-B2 | Formulations and methods for skin care | AMILYFE, LLC (US) | 2025-03-04 | — | — | US | disclosed |
| US-20250000767-A1 | FORMULATIONS AND METHODS FOR SKIN REGENERATION | AMILYFE, LLC | 2025-01-02 | — | — | US | disclosed |
| EP-4460290-A2 | FORMULATIONS AND METHODS FOR SKIN CARE | Entrinsic, LLC (US) | 2024-11-13 | — | — | EP | disclosed |
| US-20240350571-A1 | FORMULATIONS AND METHODS FOR SKIN CARE | AMILYFE, LLC | 2024-10-24 | — | — | US | disclosed |
| US-20240350388-A1 | FORMULATIONS AND METHODS FOR SKIN CARE OR HYALURONIC ACID SYNTHESIS | AMILYFE, LLC | 2024-10-24 | — | — | US | disclosed |
| CN-109890836-B | Wound healing peptides | 詹姆斯库克大学 | 2024-04-19 | — | — | CN | disclosed |
| EP-4216982-A2 | VARIANT STAPHYLOCOCCUSAUREUS LUKA AND LUKB POLYPEPTIDES AND VACCINE COMPOSITIONS | Janssen Pharmaceuticals, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| WO-2023130094-A2 | FORMULATIONS AND METHODS FOR SKIN CARE | Entrinsic, LLC (US) | 2023-07-06 | — | — | WO | disclosed |
| US-20230201151-A1 | FORMULATIONS AND METHODS FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME, ASTHMA, OR ALLERGIC RHINITIS | Entrinsic, LLC | 2023-06-29 | — | — | US | disclosed |
| EP-4157218-A1 | FORMULATIONS AND METHODS FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME, ASTHMA, OR ALLERGIC RHINITIS | University of Florida Research Foundation, Inc. (US) | 2023-04-05 | — | — | EP | disclosed |
| CN-115838415-A | Hookworm Kunitz polypeptide and anticoagulation application thereof | 湖北医药学院 | 2023-03-24 | — | — | CN | disclosed |
| EP-3507300-B1 | WOUND HEALING PEPTIDE | UNIV JAMES COOK (AU) | 2022-12-28 | — | — | EP | disclosed |
| US-11458155-B1 | Active ingredient complexes, compositions and methods for hangover relief and to ameliorate alcohol-induced liver damage | Fulgent Life Inc. (US) | 2022-10-04 | — | — | US | disclosed |
| CN-115078738-A | Application of inhibitor of L1CAM protein N979 site-specific core fucosylation | 复旦大学 | 2022-09-20 | — | — | CN | disclosed |
| WO-2022067255-A2 | VARIANT STAPHYLOCOCCUS AUREUS LUKA AND LUKB POLYPEPTIDES AND VACCINE COMPOSITIONS | Janssen Pharmaceuticals, Inc. (US) | 2022-03-31 | — | — | WO | disclosed |